De Lille A J, Silvers M L, Cadario M E, Tran T Q, Cage C L, LeBlanc M M
Department of Physiology, Animal Reproduction and Biotechnology Laboratory, Colorado State University, Fort Collins, Colorado, USA.
J Reprod Fertil Suppl. 2000(56):373-9.
The effects of the sedatives xylazine (predominantly alpha2 agonist) and acepromazine (predominantly alpha1 antagonist) and their influence on intrauterine pressure were measured in four reproductively normal mares and four mares with delayed uterine clearance. Intrauterine pressure was measured in each mare during oestrus for three 100 min periods using an 8-F catheter with three discrete pressure sensors. After 10 min of baseline recording, xylazine, acepromazine or saline was administered i.v. Oxytocin was administered i.v. after a further 30 min, and pressure recordings were continued for 60 min. The pressure changes analysed were: number of uterine contractions; time of onset and duration of the first contraction; and the time at which intrauterine pressure changed from baseline. Data were analysed using the mixed procedure of the Statistical Analysis System. ANOVA detected an effect of treatment (P < 0.0001) and a treatment by group interaction (P < 0.001). Xylazine administration caused a tetanic contraction in all mares. When mares with delayed uterine clearance were sedated with xylazine before administration of oxytocin, the duration of increased intrauterine pressure was longer than that of normal mares (24.87 +/- 2.52 and 15.81 +/- 2.46, respectively; P < 0.0001). Acepromazine administration had no effect on the oxytocin-induced contraction pattern in normal mares, but there was a decrease in the number of contractions in mares with delayed uterine clearance. The enhanced response to alpha-agonists and -antagonists observed in mares with delayed uterine clearance when the drugs were administered before oxytocin may be due to denervation supersensitivity. After mating, sedation of mares with xylazine is preferred to sedation with acepromazine, as xylazine increases uterine contraction time.
在4匹生殖功能正常的母马和4匹子宫清除延迟的母马中,测量了镇静剂赛拉嗪(主要为α2激动剂)和乙酰丙嗪(主要为α1拮抗剂)的作用及其对子宫内压的影响。在发情期,使用带有三个离散压力传感器的8F导管,在每匹母马中测量三个100分钟时间段的子宫内压。在记录10分钟基线后,静脉注射赛拉嗪、乙酰丙嗪或生理盐水。再过30分钟后静脉注射催产素,并持续记录压力60分钟。分析的压力变化包括:子宫收缩次数;第一次收缩的起始时间和持续时间;以及子宫内压从基线变化的时间。使用统计分析系统的混合程序分析数据。方差分析检测到治疗效果(P < 0.0001)和治疗与组间的交互作用(P < 0.001)。注射赛拉嗪会使所有母马发生强直性收缩。在注射催产素前用赛拉嗪对子宫清除延迟的母马进行镇静时,子宫内压升高的持续时间比正常母马更长(分别为24.87±2.52和15.81±2.46;P < 0.0001)。注射乙酰丙嗪对正常母马催产素诱导的收缩模式没有影响,但子宫清除延迟的母马收缩次数减少。在注射催产素前给子宫清除延迟的母马注射药物时,观察到它们对α激动剂和拮抗剂的反应增强,这可能是由于去神经超敏反应。配种后,用赛拉嗪对母马进行镇静比用乙酰丙嗪更可取,因为赛拉嗪会增加子宫收缩时间。